• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

免疫性血小板减少症与免疫球蛋白G4相关性疾病之间存在关联吗?

Is There a Correlation Between Immune Thrombocytopenia and Immunoglobulin G4-Related Disease?

作者信息

Lame Dorela, Pianelli Michelangelo, Morsia Erika, Olivieri Attilio, Poloni Antonella

机构信息

Universita Politecnica delle Marche, AOU delle Marche, Ancona, Italy.

出版信息

J Hematol. 2024 Aug;13(4):174-177. doi: 10.14740/jh1260. Epub 2024 Aug 15.

DOI:10.14740/jh1260
PMID:39247064
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11379049/
Abstract

Immunoglobulin G4-related disease (IgG4-RD) is an immune-mediated condition causing organ swelling and fibrosis. Rarely, it coexists with primary immune thrombocytopenia (ITP), characterized by low platelet count (< 100 × 10/L) without an underlying cause. We present a case of a 56-year-old woman diagnosed with ITP in 2005, successfully treated with dexamethasone and intravenous immunoglobulins (IVIG). In 2011, she was diagnosed with IgG4-RD, type I autoimmune pancreatitis, initially treated with steroids then azathioprine with no response. ITP relapses were managed with prednisone/IVIG, rituximab, and thrombopoietin-receptor agonist therapy. Fostamatinib provided temporary relief, but platelet count dropped again in 2023. Combination therapy with small doses of prednisone and mycophenolate showed a partial response, maintaining platelet count over 50 × 10/L. Further investigation is warranted to explore any correlation between these two conditions, especially considering the patient's prolonged response to immunosuppressors.

摘要

免疫球蛋白G4相关性疾病(IgG4-RD)是一种免疫介导的疾病,可导致器官肿胀和纤维化。它很少与原发性免疫性血小板减少症(ITP)共存,ITP的特征是血小板计数低(<100×10⁹/L)且无潜在病因。我们报告一例56岁女性病例,该患者于2005年被诊断为ITP,接受地塞米松和静脉注射免疫球蛋白(IVIG)治疗成功。2011年,她被诊断为IgG4-RD,I型自身免疫性胰腺炎,最初用类固醇治疗,然后用硫唑嘌呤治疗,但无反应。ITP复发采用泼尼松/IVIG、利妥昔单抗和血小板生成素受体激动剂治疗。福斯他替尼提供了暂时缓解,但2023年血小板计数再次下降。小剂量泼尼松和霉酚酸酯联合治疗显示出部分反应,使血小板计数维持在50×10⁹/L以上。鉴于患者对免疫抑制剂的长期反应,有必要进一步研究这两种疾病之间的相关性。

相似文献

1
Is There a Correlation Between Immune Thrombocytopenia and Immunoglobulin G4-Related Disease?免疫性血小板减少症与免疫球蛋白G4相关性疾病之间存在关联吗?
J Hematol. 2024 Aug;13(4):174-177. doi: 10.14740/jh1260. Epub 2024 Aug 15.
2
[Diagnostic approach and treatment of immune thrombocytopenia in adults].[成人免疫性血小板减少症的诊断方法与治疗]
Acta Med Croatica. 2013 Mar;67(1):3-11.
3
Complement activation negatively affects the platelet response to thrombopoietin receptor agonists in patients with immune thrombocytopenia: a prospective cohort study.补体激活可负向影响免疫性血小板减少症患者对血小板生成素受体激动剂的血小板反应:一项前瞻性队列研究。
Platelets. 2023 Dec;34(1):2159019. doi: 10.1080/09537104.2022.2159019.
4
Real-world use of thrombopoietin receptor agonists for the management of immune thrombocytopenia in adult patients in the United Kingdom: Results from the TRAIT study.英国成人免疫性血小板减少症患者使用血小板生成素受体激动剂的真实世界数据:TRAIT 研究结果。
Br J Haematol. 2024 Jun;204(6):2442-2452. doi: 10.1111/bjh.19345. Epub 2024 Mar 1.
5
Immune thrombocytopenia: Pathophysiology and impacts of Romiplostim treatment.免疫性血小板减少症:发病机制和罗米司亭治疗的影响。
Blood Rev. 2024 Sep;67:101222. doi: 10.1016/j.blre.2024.101222. Epub 2024 Jun 20.
6
Impact of pre-delivery medication treatment on delivery outcome in patients with primary immune thrombocytopenia: a cohort study.预先药物治疗对原发性免疫性血小板减少症患者分娩结局的影响:一项队列研究。
Platelets. 2024 Dec;35(1):2380366. doi: 10.1080/09537104.2024.2380366. Epub 2024 Aug 1.
7
Successful eltrombopag treatment of severe refractory thrombocytopenia in chronic myelomonocytic leukemia: Two cases reports: A CARE-compliant article.艾曲泊帕成功治疗慢性粒单核细胞白血病严重难治性血小板减少症:两例报告:一篇遵循CARE原则的文章
Medicine (Baltimore). 2017 Oct;96(43):e8337. doi: 10.1097/MD.0000000000008337.
8
Successful treatment of tubulointerstitial nephritis in immunoglobulin G4-related disease with rituximab: A case report.利妥昔单抗成功治疗免疫球蛋白G4相关疾病中的肾小管间质性肾炎:一例报告
World J Clin Cases. 2019 Aug 26;7(16):2309-2315. doi: 10.12998/wjcc.v7.i16.2309.
9
Treatment patterns and outcomes of second-line rituximab and thrombopoietin receptor agonists in adult immune thrombocytopenia: A Canadian retrospective cohort study.二线利妥昔单抗和血小板生成素受体激动剂在成人免疫性血小板减少症中的治疗模式和结局:一项加拿大回顾性队列研究。
Thromb Res. 2022 Dec;220:5-11. doi: 10.1016/j.thromres.2022.09.021. Epub 2022 Sep 29.
10
Chronic immune thrombocytopenia in a child responding only to thrombopoietin receptor agonist.一名儿童慢性免疫性血小板减少症仅对血小板生成素受体激动剂有反应。
Sudan J Paediatr. 2012;12(2):60-4.

本文引用的文献

1
The Role of IgG4 in Autoimmunity and Rheumatic Diseases.IgG4 在自身免疫和风湿性疾病中的作用。
Front Immunol. 2022 Jan 25;12:787422. doi: 10.3389/fimmu.2021.787422. eCollection 2021.
2
Recent advances in the mechanisms and treatment of immune thrombocytopenia.免疫性血小板减少症发病机制及治疗的新进展。
EBioMedicine. 2022 Feb;76:103820. doi: 10.1016/j.ebiom.2022.103820. Epub 2022 Jan 21.
3
IgG4-related disease with multiorgan involvement: a case-based review.IgG4 相关疾病多器官受累:基于病例的综述。
Rheumatol Int. 2021 Jun;41(6):1169-1174. doi: 10.1007/s00296-021-04848-w. Epub 2021 Apr 21.
4
European Guideline on IgG4-related digestive disease - UEG and SGF evidence-based recommendations.《IgG4 相关消化系统疾病欧洲指南——UEG 和 SGF 循证推荐》。
United European Gastroenterol J. 2020 Jul;8(6):637-666. doi: 10.1177/2050640620934911. Epub 2020 Jun 18.
5
Updated international consensus report on the investigation and management of primary immune thrombocytopenia.更新的原发性免疫性血小板减少症的调查和管理国际共识报告。
Blood Adv. 2019 Nov 26;3(22):3780-3817. doi: 10.1182/bloodadvances.2019000812.
6
Epidemiology and Clinical Manifestations of Immune Thrombocytopenia.免疫性血小板减少症的流行病学和临床表现。
Hamostaseologie. 2019 Aug;39(3):238-249. doi: 10.1055/s-0039-1683416. Epub 2019 Mar 13.
7
IgG4-related diseases.IgG4 相关疾病。
Best Pract Res Clin Rheumatol. 2012 Aug;26(4):425-38. doi: 10.1016/j.berh.2012.07.001.
8
The IgG subclasses of platelet-associated autoantibodies directed against platelet glycoproteins IIb/IIIa in patients with idiopathic thrombocytopenic purpura.特发性血小板减少性紫癜患者中针对血小板糖蛋白IIb/IIIa的血小板相关自身抗体的IgG亚类。
Br J Haematol. 2003 Sep;122(5):818-24. doi: 10.1046/j.1365-2141.2003.04509.x.
9
Differences in IgG subclass do not effect immune complex-enhanced T cell activation despite differential binding to antigen presenting cells.尽管IgG亚类与抗原呈递细胞的结合存在差异,但这些差异并不影响免疫复合物增强的T细胞活化。
Hum Immunol. 1999 Jun;60(6):469-78. doi: 10.1016/s0198-8859(99)00023-3.
10
Workshop on autoimmune (idiopathic) thrombocytopenic purpura: pathogenesis and new approaches to therapy.
Am J Hematol. 1998 Jul;58(3):231-4. doi: 10.1002/(sici)1096-8652(199807)58:3<231::aid-ajh12>3.0.co;2-c.